Novavax Busca Voluntarios para Ensayos de Vacunas COVID-19
Novavax, una empresa de desarrollo de vacunas con sede en Gaithersburg, ha iniciado la Fase 3 para su candidata a vacuna COVID-19. Es el quinto candidato en alcanzar la Fase… Read More
novavax
Novavax Looking for Volunteers for COVID-19 Vaccine Trials
Novavax, a vaccine development company headquartered in Gaithersburg, has initiated Phase 3 for its COVID-19 vaccine candidate. It is the fifth candidate to reach Phase 3 in the U.S., after… Read More
Novavax Ingresa a la Fase 3 de Pruebas para la Vacuna COVID-19
Novavax, que tiene su sede en Gaithersburg e instalaciones en Rockville, anunció que ha pasado a la Fase 3 de su ensayo de eficacia para su vacuna COVID-19. Prevent-19 está… Read More
Close to ‘Finish Line,’ Novavax Enters Phase 3 Trials for COVID-19 Vaccine
Novavax, which is headquartered in Gaithersburg and has facilities in Rockville, announced it has moved into Phase 3 of its efficacy trial for its COVID-19 vaccine. Prevent-19 is designed to… Read More
Montgomery County’s Life Sciences Industry Expanding During the Pandemic
The COVID-19 pandemic has not hurt all industries. In Montgomery County, the life sciences sector, in particular, is expanding. “The pandemic has clearly taken a huge toll on not just… Read More
Novavax Releases $1.6 Billion Government Contract for COVID-19 Vaccine
Novavax, a vaccine development company in Gaithersburg, Md., released details for a $1.6 billion government contract for a COVID-19 vaccine on Nov. 11, according to NPR. The contract is part… Read More
Biotech Company Working on COVID-19 Vaccine Announces Addition of 400 Jobs
A Gaithersburg company currently working on a COVID-19 vaccine announced it is expanding and expects to add 400 new jobs by the end of 2024, with most of the new… Read More
Hogan Tours Vaccine Development Company Novavax in Gaithersburg
On Thursday, Gov. Larry Hogan toured Novavax, a Gaithersburg company that is developing a COVID-19 vaccine. The vaccine candidate is currently in Phase 2 of clinical trials in the U.S.,… Read More
Novavax Llega a un Acuerdo con Canadá para Suministrar la Vacuna COVID-19
La empresa de biotecnología de Gaithersburg, Novavax, anunció el lunes que llegó a un acuerdo para administrar a Canadá hasta 76 millones de dosis de la vacuna COVID-19 de Novavax.… Read More
Novavax Reaches Agreement With Canada to Supply COVID-19 Vaccine
Gaithersburg biotechnology company Novavax announced Monday that it has reached an agreement in principle to give Canada up to 76 million doses of Novavax’s COVID-19 vaccine. In a statement the… Read More
Gaithersburg-Based Novavax Included in New York Times’ Coronavirus Vaccine Tracker
The New York Times has published a coronavirus vaccine tracker that shows the progress of the more than 165 vaccines in development, and the 30 that are in human trials.… Read More
Novavax’s COVID-19 Vaccine Generates Positive Results in Phase 1 Trial
The Gaithersburg-based biotechnology company Novavax reported positive results Tuesday in phase 1 of its clinical trial for a potential COVID-19 vaccine. Promising news #MadeInMontgomery. https://t.co/rC2H7EkGQf — Montgomery Council (@MoCoCouncilMD) August… Read More